+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Detection of novel cancer-testis antigen-specific T-cell responses in TIL, regional lymph nodes, and PBL in patients with esophageal squamous cell carcinoma



Detection of novel cancer-testis antigen-specific T-cell responses in TIL, regional lymph nodes, and PBL in patients with esophageal squamous cell carcinoma



Cancer Science 99(7): 1448-1454



We recently identified three HLA-A2402-restricted epitope peptides derived from cancer-testis antigens (CTA), TTK protein kinase (TTK), lymphocyte antigen 6 complex locus K (LY6K), and insulin-like growth factor (IGF)-II mRNA binding protein 3 (IMP-3) for the development of immunotherapies against esophageal squamous cell carcinoma (ESCC). In order to evaluate their immunotherapeutic potential in ESCC patients, we estimated by ELISPOT assay the TTK-, LY6K-, or IMP-3-specific T-cell immune responses in tumor-infiltrating lymphocytes (TIL), regional lymph node lymphocytes (RLNL), and peripheral blood lymphocytes (PBL) expanded from 20HLA-A2402 (+) ESCC patients, and correlated their immune activity with the expression levels of TTK, LY6K, and IMP-3, and MHC class I in the tumors. Induction of TTK-antigen specific T-cell response in TIL to the peptide-pulsed target cells was detected in 14 out of 20 (70%) cases, while LY6K or IMP-3 specific T-cell activity was observed in 11 of 20 (55%) or in eight of 20 (40%) cases, respectively. Furthermore, T-cell activity in RLNL and PBL was detectable in the similar proportion of the 20 ESCC patients. Interestingly, CTA-specific T-cell immune response was found in 13 of 14 (93%) TIL obtained from ESCC tumors with strong MHC class I expression, while it could be observed only in two of six (33%) TIL from ESCC tumors with weak MHC class I expression. These results strongly suggest the pre-existence of specific T-cell responses to HLA-A24-restricted epitope peptides from TTK, LY6K, and IMP-3 in ESCC patients. Monitoring antigen-specific T-cell responses, as well as the expression levels of MHC class I and epitope CTA in tumors, should be a selection index for application of cancer vaccine therapies to the patients who are likely to show good immune response.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 030855032

Download citation: RISBibTeXText

PMID: 18452554

DOI: 10.1111/j.1349-7006.2008.00844.x


Related references

Metastasis to peripheral glands as the first symptom of malignant tumors. Tumori 40(4): 403-409, 1954

Extensive lymphangioma of scrotum, penis and adjacent areas; report of a case. Journal of Urology 58(6): 453-457, 1947

In vivo endothelialization and neointimal hyperplasia assessment after angioplasty of sheep carotid artery with a novel polycarbonate polyurethane patch. Journal of Biomaterials Applications 34(2): 208-218, 2019

Prognostic Significance of Cutaneous Adverse Events Associated With Pembrolizumab Therapy. JAMA Oncology 1(9): 1340-1341, 2015

Early prenatal detection of a fast-growing fetal epignathus. Journal of Obstetrics and Gynaecology Research 38(11): 1328-1330, 2012

Vaccination with peptide mimotopes produces antibodies recognizing bacterial capsular polysaccharides. Vaccine 28(39): 6425-6435, 2010

Squamous cell carcinoma antigen (SCC Ag) in the diagnosis and prognosis of lung cancer. Chest 105(3): 773-776, 1994

Investigation of MDM2 Oncogene Copy Number Alterations in Cases of Chronic Lymphocytic Leukemia. Turkish Journal of Haematology 36(2): 126-127, 2019

Impact of the novel anti-convulsant vigabatrin on functional recovery following brain lesion. Restorative Neurology and Neuroscience 14(1): 35-45, 1999

New classification for juvenile idiopathic arthritis: Is the Tower of Babel falling?. Joint Bone Spine 85(2): 139-141, 2018

Studies on cell mediated immunity in hepatitis b vaccinees. Sapporo Medical Journal 55(6): 545-564, 1986

Prognosis of patients with diffuse large B cell lymphoma not reaching complete response or relapsing after frontline chemotherapy or immunochemotherapy. Annals of Hematology 94(5): 803-812, 2015

CyclinD1, a prominent prognostic marker for endometrial diseases. Diagnostic Pathology 8: 138, 2013

Correlation Between Spirometry Dates and Special Allergen- Specific Ige in Patients with Bronchial Asthma in West Georgia. Georgian Medical News 2017(266): 86-88, 2017

Surgeons should not willingly believe what they wish. The Journal of Thoracic and Cardiovascular Surgery 157(3): e117-e118, 2019